8-K
Current Report
SELLAS Life Sciences Group, Inc. Filed Acc 0001390478-15-000068
Agreement ended · Acquisition or sale completed · Exit or restructuring costs
- Item 1.02 Termination of a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading gale-201512298xkzuplenzclo.htm…